Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Hermes Pharma to invest € 25 million to bolster manufacturing capabilities for oral dosage forms
, /in E-News /by panglobalGermany-based Hermes Pharma, a leading expert in user-friendly oral dosage forms, has announced it will invest €25 million to further bolster its manufacturing capabilities. The investment will arm the company with new equipment, increased production and storage capacity, and greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. As […]
CN Bio appoints Neil Rumbelow as director of product development
, /in E-News /by panglobalCN Bio, a leading UK Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems, has appointed Neil Rumbelow as director of product development.
Thermo Fisher plans to expand into proteomics with Olink acquisition
, /in E-News /by panglobalFollowing agreement by the respective boards of directors, Thermo Fisher Scientific in mid-October announced plans to acquire Olink Holding for US$3.1 billion. The acquisition will enable Thermo Fisher to expand into proteomics and complement its platforms in life sciences and mass spectrometry. Olink offers solutions for advanced proteomics discovery and development.
New cleanrooms prompt search for better monitoring system
, /in E-News /by panglobalDuring preparations for the construction of two new cleanroom facilities, NorthX Biologics, a leading Swedish biological drug manufacturer and process developer, reviewed its environmental monitoring and control procedures, and decided to switch to a new Vaisala system, including almost 150 monitoring locations within cleanrooms and associated facilities.
HeartBeat.bio raises €4.5 million to drive development of organoid screening platform for cardiac drug discovery
, /in E-News /by panglobalHeartBeat.bio AG, a biotech company building a highly scalable human organoid and AI-supported drug discovery platform for heart disease, has closed a €4.5 million pre-series A round co-led by i&i Biotech Fund, Invest AG, aws Gründungsfonds II, and Tensor Ventures. The financing enables the completion of a ready-to-use, fully integrated, automated, high-throughput Cardioid Drug Discovery […]
Cerba research announces new collective focus on transforming research and advancing health
, /in E-News /by panglobalBelgium-based Cerba Research, a leading global clinical trial laboratory service provider owned by Cerba HealthCare, is transforming into a multi-specialist and central laboratory company, providing research organisations with even greater access to exceptional scientific and technical teams in multiple therapeutic areas for drug and vaccine development.
The growing spectrum of neural autoantibodies and associated syndromes
, /in Featured Articles /by panglobalBy Dr Jacqueline Gosink Autoimmune neurology is a rapidly growing field driven by the ongoing discovery of novel neural autoantibodies associated with recognizable clinical syndromes. These diseases can affect the central, peripheral and autonomic nervous systems and may co-occur with cancer. Today’s testing landscape encompasses more than 60 neural autoantibodies targeting different intracellular proteins, receptors […]
Tumour markers in lung cancer: modelling strategies for interpretation of tumour marker changes and potential clinical applications
, /in Featured Articles, Tumour Markers /by panglobalBy Dr F. van Delft, Dr M. Schuurbiers, Dr van den Heuvel and Dr H. van Rossum The development of immunotherapy and other targeted therapies has given rise to significant improvements in the treatment of non-small cell lung cancer. However, some patients do not benefit from these therapies and it is, therefore, important for a […]
The Man Van: catching prostate cancer early
, /in Featured Articles /by panglobalWe all know that detecting cancer early is the key to obtaining the best treatment outcomes. However, how do you do this when some sectors of the population struggle to access healthcare and does point-of care testing make it possible to take health screening to the people who need it? CLI caught up with Professor […]
Retinol-Binding Protein (RBP) assays, for serum and urine, by Turbidimetry and Nephelometry
, /in Product News /by panglobalTRIMERO Diagnostics offers IVD CE marked Retinol Binding Protein assays, for serum and urine samples, available for nephelometers and the most popular Clinical Chemistry analyzers present on the market.